Education
About Us
Working with TipRanks
Follow Us
Singular Health Group Ltd (AU:SHG)
ASX:SHG
SHG Stock Chart & Stats
AU$0.26
AU$0.03(15.38%)
At close: 4:00 PM EST
AU$0.26
AU$0.03(15.38%)
Day’s Range― - ―
52-Week RangeAU$0.18 - AU$0.42
Previous CloseN/A
Volume808.83K
Average Volume (3M)1.03M
Market Cap
AU$69.45M
Enterprise ValueAU$55.77M
Total Cash (Recent Filing)AU$13.68M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Feb 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding315,685,300
10 Day Avg. Volume889,327
30 Day Avg. Volume1,029,223
Financial Highlights & Ratios
PEG Ratio-0.30
Price to Book (P/B)6.82
Price to Sales (P/S)160.16
P/FCF Ratio-37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet HealthThe latest reported balance sheet shows zero debt and a large equity base, lowering near‑term solvency and refinancing urgency. This durable capital structure improvement reduces default risk and gives management time to execute strategic moves or raise capital on more favorable terms.
Industry ExposureOperating in Healthcare Information Services exposes the company to structural secular demand for digital health data and software. Over the next several months, persistent industry adoption and regulatory emphasis on digitization can support long‑term revenue opportunities if product execution and sales are effective.
Cash Flow TransparencyFree cash flow closely tracks accounting losses (~1x), indicating reported losses largely reflect real cash burn rather than hidden non‑cash items. That alignment improves predictability of cash needs, aiding clearer capital planning and financing over a multi‑month horizon.
Bears Say
Persistent UnprofitabilityThe company remains loss‑making across all reported years, with very negative gross and net margins. Persistent unprofitability undermines internal capital formation and constrains reinvestment in product, sales, and R&D, forcing reliance on external funding to sustain operations.
Top-line InstabilityA sharp revenue drop (~36% in 2025) after prior growth indicates weak product‑market fit or execution problems. Structural top‑line instability erodes operating leverage, makes cost absorption harder, and raises the probability that short‑term fixes will be needed rather than sustainable growth.
Ongoing Cash Burn & Funding RiskConsistently negative operating and free cash flow means the business cannot self‑fund its operations. Coupled with a history of leverage volatility and prior negative equity, this creates meaningful funding and recapitalization risk that can dilute shareholders or restrict strategic options.
Singular Health Group Ltd News
SHG FAQ
What was Singular Health Group Ltd’s price range in the past 12 months?
Singular Health Group Ltd lowest share price was AU$0.18 and its highest was AU$0.42 in the past 12 months.
What is Singular Health Group Ltd’s market cap?
Singular Health Group Ltd’s market cap is AU$69.45M.
When is Singular Health Group Ltd’s upcoming earnings report date?
Singular Health Group Ltd’s upcoming earnings report date is Feb 20, 2026 which is today.
How were Singular Health Group Ltd’s earnings last quarter?
Singular Health Group Ltd released its earnings results on Aug 29, 2025. The company reported -AU$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.015.
Is Singular Health Group Ltd overvalued?
According to Wall Street analysts Singular Health Group Ltd’s price is currently Overvalued.
Does Singular Health Group Ltd pay dividends?
Singular Health Group Ltd does not currently pay dividends.
What is Singular Health Group Ltd’s EPS estimate?
Singular Health Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Singular Health Group Ltd have?
Singular Health Group Ltd has 315,685,300 shares outstanding.
What happened to Singular Health Group Ltd’s price movement after its last earnings report?
Singular Health Group Ltd reported an EPS of -AU$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.692%.
Which hedge fund is a major shareholder of Singular Health Group Ltd?
Currently, no hedge funds are holding shares in AU:SHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Singular Health Group Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
252.94%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
54.61%
Trailing 12-Months
Company Description
Singular Health Group Ltd
Singular Health Group Ltd, a medical technology company, develops and commercializes volumetric rendering platform (VRP) for the 3D and virtual reality (VR) visualization of anatomy using standard radiological imagery. It offers 3Dicom Viewer, a cross-platform application that allows its users to interact with standard 2D medical images; 3DicomVSP, an end-to-surgical planning platform; Health Academy, a scalable multi-lingual platform that provides templated curriculum aligned lessons; and GeoVR, a cloud platform for use in the mineral resources sector. The company was founded in 2017 and is headquartered in Subiaco, Australia.
Technical Analysis
Mach7 Technologies
―
Beamtree Holdings Ltd
―
―
Alcidion Group Limited
―
PainChek Ltd
―
Options Prices
Currently, No data available
---